STARR KEVIN P

CIK 000119260324 companiesCAMBRIDGE, MA

SEC Profile

Transactions

Companies

Filings

CIK

0001192603

Recent Transactions

50 trades

Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2023-06-15+10,000→ 10,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2022-06-16+9,947→ 9,947 total
Purchase
Sage Therapeutics, Inc.
Common Stock
2021-06-16$56.05/sh+17,842→ 320,659 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2021-06-10+10,000→ 10,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2020-06-09+10,000→ 10,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2019-06-05+10,000→ 10,000 total
Sale
Sage Therapeutics, Inc.
Common Stock
2019-02-12−0→ 0 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2018-06-06+10,000→ 10,000 total
Sale
Sage Therapeutics, Inc.
Common Stock
2018-04-18$168.28/sh−24,000→ 302,817 total
Sale
Sage Therapeutics, Inc.
Common Stock
2018-04-17$169.25/sh−35,000→ 326,817 total
Other
MyoKardia, Inc.
Common Stock
2018-03-07−2,000,000→ 885,104 total
Other
Sage Therapeutics, Inc.
Common Stock
2018-02-16−510,554→ 37,362 total
Sale
MyoKardia, Inc.
Common Stock
2018-01-03$42.00/sh−816,326→ 680,272 total
Other
MyoKardia, Inc.
Common Stock
2017-12-06−2,000,000→ 2,885,104 total
Sale
MyoKardia, Inc.
Common Stock
2017-10-03$40.28/sh−75,313→ 70,763 total
Other
MyoKardia, Inc.
Common Stock
2017-09-28−2,000,000→ 4,885,104 total
Other
Sage Therapeutics, Inc.
Common Stock
2017-09-27−545,000→ 547,916 total
Sale
MyoKardia, Inc.
Common Stock
2017-09-26$43.00/sh−400,000→ 6,885,104 total
Sale
MyoKardia, Inc.
Common Stock
2017-09-25$43.00/sh−201,400→ 7,285,104 total
Sale
MyoKardia, Inc.
Common Stock
2017-09-08$42.39/sh−900→ 7,486,504 total
Sale
MyoKardia, Inc.
Common Stock
2017-09-08$41.00/sh−200,350→ 7,487,404 total
Other
Sage Therapeutics, Inc.
Common Stock
2017-07-18−800,000→ 1,092,916 total
Award
MyoKardia, Inc.
Stock Option (Right to Buy)
2017-06-14+11,000→ 11,000 total
Award
Sage Therapeutics, Inc.
Stock Option (Right to Buy)
2017-06-07+14,000→ 14,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2017-06-02+11,250→ 11,250 total
Sale
CytomX Therapeutics, Inc.$CTMX
Common Stock
2017-04-12$16.36/sh−28,357→ 31,419 total
Other
MyoKardia, Inc.
Common Stock
2017-03-30−850,000→ 7,687,754 total
Other
Sage Therapeutics, Inc.
Common Stock
2017-01-23−1,000,000→ 1,892,916 total
Sale
Blueprint Medicines Corp
Common Stock
2016-12-19$28.19/sh−106,489→ 0 total
Sale
Global Blood Therapeutics, Inc.
Common Stock
2016-12-16$16.00/sh−108,955→ 82,544 total
Other
MyoKardia, Inc.
Common Stock
2016-11-29−850,000→ 8,537,754 total
Sale
Editas Medicine, Inc.$EDIT
Common Stock
2016-09-06$15.90/sh−5,890→ 0 total
Other
Sage Therapeutics, Inc.
Common Stock
2016-08-19−1,000,000→ 2,892,916 total
Award
Sage Therapeutics, Inc.
Stock Options (Right to buy)
2016-06-22$28.35/sh+13,922→ 13,922 total
Award
MyoKardia, Inc.
Stock Option (Right to Buy)
2016-06-07+11,000→ 11,000 total
Award
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2016-06-03+11,250→ 11,250 total
Sale
Sage Therapeutics, Inc.
Common Stock
2016-05-16$31.25/sh−850,000→ 3,892,916 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2015-11-12$101.58/sh−1,200→ 900 total
Other
Sage Therapeutics, Inc.
Common Stock
2015-11-12−109,832→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2015-11-12$15.82/sh+25,000→ 37,500 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2015-11-12$103.01/sh−900→ 0 total
Other
Sage Therapeutics, Inc.
Common Stock
2015-11-12+109,832→ 109,832 total
Other
Sage Therapeutics, Inc.
Common Stock
2015-11-12+15,986→ 65,227 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2015-11-12−12,500→ 0 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2015-11-12$11.33/sh+12,500→ 12,500 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2015-11-12$100.01/sh−35,400→ 2,100 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Stock Option (right to buy)
2015-11-12−25,000→ 0 total
Other
Sage Therapeutics, Inc.
Common Stock
2015-11-12−1,700,000→ 4,742,916 total
Sale
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2015-11-11$105.31/sh−2,274→ 35,226 total
Exercise/Conversion
ALNYLAM PHARMACEUTICALS, INC.$ALNY
Common Stock
2015-11-11$9.30/sh+25,000→ 25,000 total

Companies

Recent Filings

Address

300 THIRD STREET

CAMBRIDGE, MA, 02142

View on SEC.gov